Logotype for Luye Pharma Group Ltd

Luye Pharma Group (2186) investor relations material

Luye Pharma Group H1 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Luye Pharma Group Ltd
H1 2025 earnings summary28 Aug, 2025

Executive summary

  • Revenue rose 3.5% year-over-year to RMB3,181.1 million in H1 2025, driven by key product sales in oncology and CNS segments.

  • Net profit declined 18.4% year-over-year to RMB357.4 million, mainly due to higher selling, distribution, and finance costs.

  • Gross profit increased 3.8% to RMB2,157.6 million, with a gross margin of 67.8%.

  • No interim dividend declared for H1 2025.

  • Focuses on innovative pharmaceuticals in oncology, CNS, cardiovascular, and metabolism, with a global footprint in over 80 countries and strong R&D capabilities.

Financial highlights

  • EBITDA: RMB1,204.2 million (+4.2% YoY); EPS: RMB8.32 cents (vs. RMB10.31 cents YoY).

  • Selling and distribution expenses rose 19.7% to RMB1,018.8 million, now 32.0% of revenue.

  • Administrative expenses increased 9.1% to RMB315.5 million; other expenses dropped 36.2% to RMB213.0 million, mainly due to lower R&D costs.

  • Finance costs rose 21.9% to RMB338.5 million, mainly from higher convertible bond interest.

  • Effective tax rate: 21.9% (vs. 17.3% YoY).

Outlook and guidance

  • Revenue expected to grow sustainably, supported by new product launches, insurance negotiations, and anticipated regulatory approvals.

  • Several innovative drugs may complete clinical trials or have data readouts by end-2025.

  • Anticipates approvals for aflibercept injection and denosumab BLA submissions in the UK by end-2025 and in the US in 2026.

  • Plans to strengthen sales of newly approved products and optimize R&D pipeline.

  • Several products are undergoing insurance coverage negotiations, with implementation expected in 2026 if successful.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Luye Pharma Group earnings date

Logotype for Luye Pharma Group Ltd
H2 202529 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Luye Pharma Group earnings date

Logotype for Luye Pharma Group Ltd
H2 202529 Mar, 2026

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage